Related Experiment Video
Updated: Jun 6, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Update on pediatric psoriasis, Part 2: Therapeutic management
1Pediatric and Adolescent Dermatology, St. Luke's-Roosevelt Hospital Center, 1090 Amsterdam Ave, Ste 11D, New York, NY 10025, USA. nsilverb@chpnet.org
Cutis
|December 15, 2010
Summary
Pediatric psoriasis, an autoimmune condition, requires prompt treatment to mitigate psychological effects in children. Management strategies vary based on disease severity and joint involvement.
Area of Science:
- Immunology
- Dermatology
- Pediatrics
Background:
- Pediatric psoriasis is an autoimmune disorder with complex immunologic underpinnings.
- It is frequently linked to significant psychological distress in affected children.
- Upper respiratory tract infections are a common trigger for childhood psoriasis.
Purpose of the Study:
- To outline the management of pediatric psoriasis.
- To emphasize the importance of addressing psychological morbidity in children with psoriasis.
- To review current and emerging treatment options.
Main Methods:
- Treatment selection is guided by disease severity and the presence of joint involvement.
- Topical treatments include corticosteroids and calcipotriene.
- Systemic therapies such as UV light, retinoids, cyclosporine, methotrexate, and etanercept are employed.
Main Results:
- Various therapeutic agents effectively manage cutaneous psoriatic lesions.
- Methotrexate sodium and etanercept demonstrate efficacy in treating both skin and joint manifestations.
- Prompt and effective treatment is crucial for limiting psychologic effects.
Conclusions:
- Effective management of pediatric psoriasis necessitates a comprehensive approach.
- Addressing psychological symptoms and supporting psychological growth is vital.
- Treatment strategies should be tailored to individual patient needs, considering disease severity and comorbidities.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...